Heart-on-a-chip (HoC) platforms represent a cutting-edge convergence of microfluidics and cellular biology, designed to imitate the complex physiological, electrical, and mechanical environments of a human heart. HoC devices are used to culture and observe cardiac cells in a highly customizable environment while allowing for real-time observations. However, current HoC systems face critical translational bottlenecks. Most notably, laboratory-grown cardiomyocytes consistently exhibit structural and functional immaturity and a lack of cellular complexity. This review evaluates recent engineering and biological strategies engineered to address these limitations. We dissect advancements in multicellular co-culture, biomimetic electrical/mechanical stimulation regimes, and microvascular fabrication techniques aimed at driving functional cell maturation. Finally, we highlight current cardiac model applications, existing challenges, and future perspectives.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: